000 01481 a2200445 4500
005 20250516125231.0
264 0 _c20140424
008 201404s 0 0 eng d
022 _a1099-0496
024 7 _a10.1002/ppul.22741
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSawicki, Gregory S
245 0 0 _aA pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care.
_h[electronic resource]
260 _bPediatric pulmonology
_cOct 2013
300 _a954-61 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAnti-Bacterial Agents
_xadministration & dosage
650 0 4 _aCystic Fibrosis
_xdrug therapy
650 0 4 _aDeoxyribonuclease I
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLogistic Models
650 0 4 _aLung
_xphysiopathology
650 0 4 _aMale
650 0 4 _aRecombinant Proteins
_xadministration & dosage
650 0 4 _aRisk Factors
650 0 4 _aTobramycin
_xadministration & dosage
650 0 4 _aYoung Adult
700 1 _aAyyagari, Rajeev
700 1 _aZhang, Jie
700 1 _aSignorovitch, James E
700 1 _aFan, Liangyi
700 1 _aSwallow, Elyse
700 1 _aLatremouille-Viau, Dominick
700 1 _aWu, Eric Q
700 1 _aShi, Lizheng
773 0 _tPediatric pulmonology
_gvol. 48
_gno. 10
_gp. 954-61
856 4 0 _uhttps://doi.org/10.1002/ppul.22741
_zAvailable from publisher's website
999 _c22360429
_d22360429